Package Insert: Information for the User
Primperan 10 mg Tablets
Metoclopramide Hydrochloride
Read this package insert carefully before starting to take this medication, as it contains important information for you.
6. Contents of the pack and additional information
Primperan is an antiemetic. It contains a medication called “metoclopramide”. It acts on an area of the brain that prevents nausea or vomiting.
Adult population
Primperan is used in adults:
Metoclopramide can be taken in combination with oral analgesics in the case of migraine so that the analgesics are more effective.
Pediatric population
Primperan is indicated in children (1-18 years of age) if other treatments do not work or cannot be used to prevent delayed nausea and vomiting that may appear after chemotherapy.
Do not administer Primperan to children under 1 year (see below “Children and adolescents”).
Do not take Primperan if any of the above cases apply to you. If you are unsure, consult your doctor, pharmacist, or nurse before taking Primperan.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before taking Primperan if:
Your doctor may perform blood tests to monitor your levels of blood pigments. In cases of abnormal levels (methemoglobinemia), treatment should be stopped immediately and permanently.
You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.
Do not exceed 3 months of treatment due to the risk of involuntary muscle spasms.
Children and adolescents
Uncontrolled movements (extrapyramidal disorders) may appear in children and young adults. This medication should not be used in children under 1 year due to the high risk of uncontrolled movements (see above “Do not take Primperan”).
Use of Primperan with other medications
Inform your doctor, pharmacist, or nurse if you are taking, have taken recently, or may need to take any other medication. This is because some medications may affect the way Primperan works or Primperan may affect the way other medications work. These medications include:
Use of Primperan with alcohol
Do not consume alcohol during treatment with metoclopramide because it increases the sedative effect of Primperan.
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Primperan may be taken during pregnancy if necessary. Your doctor will decide whether to administer this medication.
Primperan is not recommended during breastfeeding because metoclopramide passes into breast milk and may affect your baby.
Driving and operating machinery
After taking Primperan, you may feel drowsy, dizzy, or have involuntary movements of tics, jerks, or torsion and unusual muscle tone that causes distortion of your body. This may affect your vision and also interfere with your ability to drive and operate machinery.
Primperan 10 mg tablets contain lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
All indications (adult patients)
A single dose of 10 mg is recommended, which can be repeated up to three times a day.
The maximum recommended daily dose is 30 mg or 0.5 mg/kg of body weight.
The maximum duration of treatment is 5 days.
To prevent delayed nausea and vomiting that may appear after chemotherapy (children 1-18 years old)
The recommended dose is 0.1 to 0.15 mg/kg of body weight, which can be repeated up to three times a day, taken orally.
The maximum dose in 24 hours is 0.5 mg/kg of body weight.
Dose table
Age | Body weight | Dose | Frequency |
1-3 years | 10-14 kg | 1 mg | Up to three times a day |
3-5 years | 15-19 kg | 2 mg | Up to three times a day |
5-9 years | 20-29 kg | 2.5 mg | Up to three times a day |
9-18 years | 30-60 kg | 5 mg | Up to three times a day |
15-18 years | More60 kg | 10 mg | Up to three times a day |
This medication should not be taken for more than 5 days to prevent delayed nausea and vomiting that may appear after chemotherapy.
Primperan tablets are not suitable for use in children with a body weight less than61 kg. Other pharmaceutical forms/doses may be more suitable for administration (e.g. oral solution or injectable solution).
Administration form
Wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.
Special populations
Geriatric population
It may be necessary to reduce the dose depending on kidney problems, liver problems, and general health problems.
Other pharmaceutical forms/doses may be more suitable for administration (e.g. oral solution or injectable solution).
Adults with renal problems
Inform your doctor if you have kidney problems. The dose should be reduced if you have moderate to severe kidney problems.
This presentation is not suitable for administration. Other pharmaceutical forms/doses may be more suitable for administration (e.g. oral solution or injectable solution).
Adults with liver problems
Inform your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.
This presentation is not suitable for administration. Other pharmaceutical forms/doses may be more suitable for administration (e.g. oral solution or injectable solution).
Children and adolescents
Metoclopramide should not be used in children under 1 year (see section 2).
If you take more Primperan than you should
Contact your doctor or pharmacist immediately. You may experience uncontrollable movements (extrapyramidal disorders), feel drowsy, have some consciousness problems, be confused, have hallucinations, and heart problems. Your doctor may prescribe treatment for these effects if necessary.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Primperan
Do not take a double dose to compensate for the missed doses.
If you have any other doubts about the use of this medication, ask your doctor, nurse, or pharmacist.
The symptoms may include rash, itching, difficulty breathing, shortness of breath, swelling of the face, lips, throat, or tongue, chills, moist skin, palpitations, dizziness, weakness, or fainting.
Immediately contact your doctor or another healthcare professional or go to the nearest hospital emergency department immediately.
Discontinue treatment and immediately report to your doctor, pharmacist, or nurse if you experience any of the following signs while taking this medication:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Unknown frequency(frequency that cannot be estimated from available data)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Store below 25°C.
Do not use Primperan after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Primperan 10 mg tablets
Appearance of the product and content of the packaging
They are flat, scored, white to off-white tablets.
They are packaged in blisters of 30 and 60 tablets for oral administration.
Other presentations:
Primperan 1 mg/ml oral solution: Bottle with 200 ml
Primperan 10 mg/2 ml injectable solution: Container with 12 ampoules of 2 ml
Marketing authorization holder
sanofi-aventis, S.A.
C/ Rosselló i Porcel, 21
08016 Barcelona
Spain
Responsible for manufacturing
Famar Health Care Services Madrid, S.A.U.
Avda. de Leganés, 62
28923 - Alcorcón (Madrid)
Spain
or
Delpharm Dijon
6, Boulevard de l’Europe
21800 Quetigny
France
Last review date of this leaflet: February 2023
The detailed information of this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.